US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

GRI BIO INC

1.38

-0.0500-3.50%

Post-market: 1.37-0.0100-0.72%19:49 EDT

Volume:43.88K

Turnover:61.79K

Market Cap:2.96M

PE:-0.02

High:1.47

Open:1.43

Low:1.37

Close:1.43

Loading ...

Overview Company News Filings

GRI Bio (GRI) Gets a Buy from Ascendiant

GRI Bio Is Maintained at Buy by Ascendiant Capital

GRI Bio Inc. Expands Share Issuance Cap to $1.76 Million Under ATM Offering Agreement

BRIEF-GRI Bio Inc - Phase 2A Study Results For GRI-0621 Expected In Q2 2025

GRI Bio Inc - Phase 2a Study Results for GRI-0621 Expected in Q2 2025

THOMSON REUTERS

GRI Bio Inc reports results for the quarter ended March 31 - Earnings Summary

GRI Bio Q1 EPS $(5.80) Misses $(4.11) Estimate

GRI Bio Inc. Expands Global Intellectual Property Portfolio with New Patents Granted in Europe and Japan

GRI Bio Inc - Cash Runway Expected to Fund Operations Through Q3 2025

THOMSON REUTERS

GRI Bio Reports First Quarter 2025 Financial Results and Confirms GRI-0621 Phase 2a Ipf Trial on Track for 6-Week Interim Data in Q2 2025 and Topline Data in Q3 2025

THOMSON REUTERS

GRI Bio Inc expected to post a loss of $4.08 a share - Earnings Preview

BRIEF-GRI Bio’s Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect Of GRI-0621

GRI Bio Inc - Interim Data Expected Q2 2025, Topline Data Q3 2025

THOMSON REUTERS

GRI Bio’s Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“Ipf”)

THOMSON REUTERS

BRIEF-GRI Bio Continues To Drive Enrollment In Ongoing Phase 2A Study Of GRI-0621 In Idiopathic Pulmonary Fibrosis

GRI Bio Continues to Drive Enrollment in Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“Ipf”)

THOMSON REUTERS

Lendlease Global Commercial Reit posts 10.4% retail rental aversion for Q3 FY2025

GoDaddy 2024 Sustainability Report: A Message From Our Chief Executive Officer

ACCESS Newswire

Nova Releases 2025 Sustainability Insight Report

OneConnect Releases ESG Report for the Third Consecutive Year, Strengthening Its Leadership in Sustainable Finance

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/GRI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GRI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRI\",,,,,undefined,":{"symbol":"GRI","market":"US","secType":"STK","nameCN":"GRI BIO INC","latestPrice":1.38,"timestamp":1749240000000,"preClose":1.43,"halted":0,"volume":43880,"hourTrading":{"tag":"盘后","latestPrice":1.37,"preClose":1.38,"latestTime":"19:49 EDT","volume":1099,"amount":1512.7824,"timestamp":1749253781520},"delay":0,"floatShares":2140900,"shares":2141473,"eps":-55.205753,"marketStatus":"Market Closed","change":-0.05,"latestTime":"06-06 16:00:00 EDT","open":1.43,"high":1.4728,"low":1.37,"amount":61792.03101200001,"amplitude":0.071888,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-55.205753,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"symbolChange":{"newSymbol":"RDOG","executeDate":"2020-01-02"},"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.43,"sharesOutstanding":1100000,"nav":47.93,"aum":52503274.57,"dividendRate":0.000725,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":1.43,"preClose":1.43,"latestTime":"08:28 EDT","volume":16,"amount":22.88,"timestamp":1749212937021},"postHourTrading":{"tag":"盘后","latestPrice":1.37,"preClose":1.38,"latestTime":"19:49 EDT","volume":1099,"amount":1512.7824,"timestamp":1749253781520},"volumeRatio":0.3563198040433367},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRI\",,,,,undefined,":{"symbol":"GRI","floatShares":2140900,"roa":"-136.04%","roe":"-467.95%","lyrEps":-55.205753,"volumeRatio":0.3563198040433367,"shares":2141473,"dividePrice":0.001,"high":1.4728,"amplitude":0.071888,"preClose":1.43,"low":1.37,"week52Low":1.1,"pbRate":"2.45","week52High":64.09,"institutionHeld":0,"latestPrice":1.38,"eps":-55.205753,"divideRate":0.000725,"volume":43880,"delay":0,"ttmEps":-55.205753,"open":1.43,"prevYearClose":14.0828,"prevWeekClose":1.35,"prevMonthClose":1.35,"prevQuarterClose":3.2,"fiveDayClose":1.35,"twentyDayClose":1.6,"sixtyDayClose":5.95},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GRI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2539234657","title":"GRI Bio (GRI) Gets a Buy from Ascendiant","url":"https://stock-news.laohu8.com/highlight/detail?id=2539234657","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539234657?lang=en_us&edition=fundamental","pubTime":"2025-05-29 15:55","pubTimestamp":1748505328,"startTime":"0","endTime":"0","summary":"Ascendiant analyst Edward Woo maintained a Buy rating on GRI Bio (GRI – Research Report) on May 27. The company’s shares closed yesterday at $1.35....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/gri-bio-gri-gets-a-buy-from-ascendiant?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/gri-bio-gri-gets-a-buy-from-ascendiant?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2538504844","title":"GRI Bio Is Maintained at Buy by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2538504844","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538504844?lang=en_us&edition=fundamental","pubTime":"2025-05-27 18:33","pubTimestamp":1748341980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GRI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 27, 2025 06:33 ET (10:33 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI"],"gpt_icon":0},{"id":"2537133103","title":"GRI Bio Inc. Expands Share Issuance Cap to $1.76 Million Under ATM Offering Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2537133103","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537133103?lang=en_us&edition=fundamental","pubTime":"2025-05-23 19:17","pubTimestamp":1747999044,"startTime":"0","endTime":"0","summary":"Gri Bio Inc. has announced an increase in the number of shares available for issuance under its At The Market Offering Agreement with H.C. Wainwright & Co., LLC. The company has filed a prospectus supplement to raise the maximum number of shares of its common stock, with a par value of $0.0001 per share. The new aggregate total of shares available for issuance is valued at up to $1,758,934. This is in addition to shares already sold under the agreement, which have an aggregate gross sales price of approximately $4,546,137. Legal opinions regarding the issuance and sale of these shares have been provided by Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gri Bio Inc. published the origi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDL7YV56w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2537946759","title":"BRIEF-GRI Bio Inc - Phase 2A Study Results For GRI-0621 Expected In Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2537946759","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537946759?lang=en_us&edition=fundamental","pubTime":"2025-05-22 20:33","pubTimestamp":1747917224,"startTime":"0","endTime":"0","summary":"BRIEF-GRI Bio Inc - Phase 2A Study Results For GRI-0621 Expected In Q2 2025May 22 (Reuters) - GRI Bio Inc GRI.O:GRI BIO INC - PHASE 2A STUDY RESULTS FOR GRI-0621 EXPECTED IN Q2 2025Source text: ID:nGNXbFByd6Further company coverage: GRI.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nFWN3RU04T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","GRI"],"gpt_icon":0},{"id":"2537945711","title":"GRI Bio Inc - Phase 2a Study Results for GRI-0621 Expected in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2537945711","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537945711?lang=en_us&edition=fundamental","pubTime":"2025-05-22 20:07","pubTimestamp":1747915671,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nFWN3RU04T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","GRI","BK4139"],"gpt_icon":0},{"id":"2535028825","title":"GRI Bio Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535028825","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535028825?lang=en_us&edition=fundamental","pubTime":"2025-05-15 21:32","pubTimestamp":1747315971,"startTime":"0","endTime":"0","summary":"GRI Bio Inc reports results for the quarter ended March 31 - Earnings SummaryGRI Bio Inc GRI.OQ reported a quarterly adjusted loss of $5.80 per share for the quarter ended March 31.  The lone analyst ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nL8N3RN1O9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI"],"gpt_icon":0},{"id":"2535840278","title":"GRI Bio Q1 EPS $(5.80) Misses $(4.11) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535840278","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535840278?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:47","pubTimestamp":1747313274,"startTime":"0","endTime":"0","summary":"GRI Bio (NASDAQ:GRI) reported quarterly losses of $(5.80) per share which missed the analyst consensus estimate of $(4.11) by 41.12 percent. This is a 94.26 percent increase over losses of $(101.05) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45435684/gri-bio-q1-eps-5-80-misses-4-11-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI"],"gpt_icon":0},{"id":"2535684085","title":"GRI Bio Inc. Expands Global Intellectual Property Portfolio with New Patents Granted in Europe and Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2535684085","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535684085?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:36","pubTimestamp":1747312604,"startTime":"0","endTime":"0","summary":"GRI Bio has bolstered its global intellectual property portfolio with the granting of patents in Europe and Japan. This development strengthens the company's position in advancing its innovative pipeline of therapies. The new patents are expected to support the company's ongoing clinical programs and enhance its potential for future growth in the international market.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gri Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 15, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nNDL28npMK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GRI","BK4139"],"gpt_icon":0},{"id":"2535408338","title":"GRI Bio Inc - Cash Runway Expected to Fund Operations Through Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2535408338","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535408338?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:35","pubTimestamp":1747312500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nPLXE05F42:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","GRI","BK4139"],"gpt_icon":0},{"id":"2535847018","title":"GRI Bio Reports First Quarter 2025 Financial Results and Confirms GRI-0621 Phase 2a Ipf Trial on Track for 6-Week Interim Data in Q2 2025 and Topline Data in Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2535847018","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535847018?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:35","pubTimestamp":1747312500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nTUA7J8DGK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRI","BK4007","BK4139"],"gpt_icon":0},{"id":"2534436647","title":"GRI Bio Inc  expected to post a loss of $4.08 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534436647","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534436647?lang=en_us&edition=fundamental","pubTime":"2025-05-09 22:42","pubTimestamp":1746801725,"startTime":"0","endTime":"0","summary":"GRI Bio Inc  expected to post a loss of $4.08 a share - Earnings Preview GRI Bio Inc GRI.OQ GRI.O is expected to report resultson May 12 (estimated) for the period ending March 31 2025LSEG's mean anal","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH29B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI"],"gpt_icon":0},{"id":"2533370881","title":"BRIEF-GRI Bio’s Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect Of GRI-0621","url":"https://stock-news.laohu8.com/highlight/detail?id=2533370881","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533370881?lang=en_us&edition=fundamental","pubTime":"2025-05-08 23:09","pubTimestamp":1746716981,"startTime":"0","endTime":"0","summary":"BRIEF-GRI Bio’s Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect Of GRI-0621May 8 (Reuters) - GRI Bio Inc GRI.O:GRI BIO’S INTERIM BIOMARKER DATA DEMONSTRATE POSITIVE TREN","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nFWN3RG1JJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","GRI"],"gpt_icon":0},{"id":"2533418743","title":"GRI Bio Inc - Interim Data Expected Q2 2025, Topline Data Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2533418743","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533418743?lang=en_us&edition=fundamental","pubTime":"2025-05-08 20:45","pubTimestamp":1746708348,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nFWN3RG1JJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2533187432","title":"GRI Bio’s Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“Ipf”)","url":"https://stock-news.laohu8.com/highlight/detail?id=2533187432","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533187432?lang=en_us&edition=fundamental","pubTime":"2025-05-08 20:45","pubTimestamp":1746708348,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nFWN3RG1JJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2533793570","title":"BRIEF-GRI Bio Continues To Drive Enrollment In Ongoing Phase 2A Study Of GRI-0621 In Idiopathic Pulmonary Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2533793570","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533793570?lang=en_us&edition=fundamental","pubTime":"2025-05-07 21:40","pubTimestamp":1746625206,"startTime":"0","endTime":"0","summary":"BRIEF-GRI Bio Continues To Drive Enrollment In Ongoing Phase 2A Study Of GRI-0621 In Idiopathic Pulmonary FibrosisMay 7 (Reuters) - GRI Bio Inc GRI.O:GRI BIO CONTINUES TO DRIVE ENROLLMENT IN ONGOING P","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nTUA5RZDB5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GRI","BK4139"],"gpt_icon":0},{"id":"2533793360","title":"GRI Bio Continues to Drive Enrollment in Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“Ipf”)","url":"https://stock-news.laohu8.com/highlight/detail?id=2533793360","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533793360?lang=en_us&edition=fundamental","pubTime":"2025-05-07 21:15","pubTimestamp":1746623700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nTUA5RZDB5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRI","BK4007"],"gpt_icon":0},{"id":"2533931996","title":"Lendlease Global Commercial Reit posts 10.4% retail rental aversion for Q3 FY2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2533931996","media":"businesstimes","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533931996?lang=en_us&edition=fundamental","pubTime":"2025-05-07 13:29","pubTimestamp":1746595784,"startTime":"0","endTime":"0","summary":"Its retail portfolio posts an occupancy rate of 99.5% for the quarter","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"bustime_highlight","url":"https://www.businesstimes.com.sg/companies-markets/lendlease-global-commercial-reit-posts-10-4-retail-rental-aversion-q3-fy2025","rn_cache_url":null,"customStyle":"","selectors":"body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.businesstimes.com.sg/companies-markets/lendlease-global-commercial-reit-posts-10-4-retail-rental-aversion-q3-fy2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bustime_highlight","symbols":["GRI","BK4139","CFA.SI","BK4007"],"gpt_icon":0},{"id":"2532882896","title":"GoDaddy 2024 Sustainability Report: A Message From Our Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2532882896","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532882896?lang=en_us&edition=fundamental","pubTime":"2025-05-02 22:30","pubTimestamp":1746196200,"startTime":"0","endTime":"0","summary":"NORTHAMPTON, MA / ACCESS Newswire / May 2, 2025 / GoDaddy:. Our mission to empower entrepreneurs everywhere, making opportunity more inclusive for all is the driving force that brings us together. GoDaddy's customers are microbusiness owners and most of them have fewer than 10 employees. According to our Venture Forward research, more than half of them are solopreneurs, both business owners and employees themselves. They are resilient and inspiring, making a difference for their families, with approximately one in three contributing 51% or more to their household income. In the U.S., they also elevate their local communities by adding seven jobs per microbusiness entrepreneur at the county level.Our integrated GoDaddy Software Platform drives innovation and growth for both our customers and us. We work to optimize AI, machine learning, monetization, experimentation, data collection, and storage using public and private cloud services to improve","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/godaddy-2024-sustainability-report-message-143000712.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4528","BK4139","LU2210150020.SGD","BK4116","LU1642822529.SGD","LU0444973449.USD","BK4585","BK4007","LU0476273544.USD","GDDY","GRI","LU2210149790.SGD","LU2095319765.USD","LU2491050154.USD","LU1815336760.USD","LU2491050071.SGD","LU0444971666.USD","LU2491049909.HKD","LU0957808578.USD","BK4588"],"gpt_icon":0},{"id":"2530707624","title":"Nova Releases 2025 Sustainability Insight Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2530707624","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530707624?lang=en_us&edition=fundamental","pubTime":"2025-04-28 19:00","pubTimestamp":1745838000,"startTime":"0","endTime":"0","summary":"REHOVOT, Israel, April 28, 2025 /PRNewswire/ -- Nova , a leading innovator and a key provider of advanced metrology and process control solutions used in semiconductor manufacturing, today announced that it has published the Company's second Sustainability Insight Report. The Report provides details on the Company's sustainability strategy, vision, and goals and progress the Company has made since the 2022 Insight Review.The Report reflects the Nova's ongoing maturation in embedding principals of sustainability, governance and social responsibility into the operating model of the company, including announcing an updated set of goals that place greater emphasis on our key environmental and social impacts that support business performance. The new report details key achievements the Company has made since the prior report, including achieving 88% renewable energy use and a significant reduction in scope 1 and 2 greenhouse gas  emissions . Additional achievements include a 35% internal mo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/nova-releases-2025-sustainability-insight-110000587.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nova-releases-2025-sustainability-insight-110000587.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GHG","SG9999000418.SGD","INAQU","BK4139","LU0278937759.USD","BK4007","NVMI","BK4142","GRI","BK4147"],"gpt_icon":0},{"id":"2530907592","title":"OneConnect Releases ESG Report for the Third Consecutive Year, Strengthening Its Leadership in Sustainable Finance","url":"https://stock-news.laohu8.com/highlight/detail?id=2530907592","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530907592?lang=en_us&edition=fundamental","pubTime":"2025-04-25 18:02","pubTimestamp":1745575320,"startTime":"0","endTime":"0","summary":"SHANGHAI, April 25, 2025 On April 24, OneConnect Financial Technology Co., Ltd  officially released its 2024 Environmental, Social, and Governance  Report. This marks the third consecutive year that OneConnect has published its ESG report, highlighting the company's ongoing commitment to corporate responsibility. The report provides a comprehensive overview of OneConnect's strategic initiatives and annual achievements across the three pillars of ESG. These efforts align closely with the \" Five Priority Areas in Finance,\", showcasing OneConnect's continued exploration and firm actions in promoting green finance, serving underbanked communities, cultivating new quality productive forces in finance, mitigating financial risks, and driving global development.In terms of institutional development, OneConnect revised and optimized over 10 core policy documents covering key risk areas such as operational risk, data security, and concentration risk management, with no major compliance violatio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/oneconnect-releases-esg-report-third-100200984.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/oneconnect-releases-esg-report-third-100200984.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4531","BK4139","ESG","PBOC","BK4007","GRI","BK4023","OCFT"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":80,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GRI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"GRI","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-5.8},{"market":"US","date":"2025-03-17","symbol":"GRI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-02-24","symbol":"GRI","defaultRemindTime":1740407400000,"type":"split","dateTimestamp":1740373200000,"forFactor":17,"toFactor":1,"ratio":17},{"market":"US","date":"2024-11-14","symbol":"GRI","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.67},{"market":"US","date":"2024-08-14","symbol":"GRI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GRI\",market:\"US\",,,undefined,":[{"executeDate":"2017-06-21","recordDate":null,"paymentDate":null,"value":0.35098,"currency":"USD"},{"executeDate":"2017-09-21","recordDate":null,"paymentDate":null,"value":0.3314,"currency":"USD"},{"executeDate":"2018-03-22","recordDate":null,"paymentDate":null,"value":0.21998,"currency":"USD"},{"executeDate":"2018-06-21","recordDate":null,"paymentDate":null,"value":0.43792,"currency":"USD"},{"executeDate":"2018-09-20","recordDate":null,"paymentDate":null,"value":0.22115,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GRI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1733803200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GRI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GRI","date":"2025-06-06","current":-0.358381,"percent":0.381679,"low":-67.389471,"twenty":-0.793245,"median":-0.205801,"eighty":-0.0953,"high":-0.026053,"avg":-0.974949,"sd":3.30086,"marketCap":3356598},"quantilePoints":[{"date":"2023-04-28","current":-6.452842,"twenty":-43.014819,"median":-6.452842,"eighty":-5.86271,"marketCap":20758792},{"date":"2023-05-05","current":-6.462034,"twenty":-6.958407,"median":-6.590723,"eighty":-6.414235,"marketCap":20788363},{"date":"2023-05-12","current":-6.241424,"twenty":-6.746989,"median":-6.452842,"eighty":-6.208332,"marketCap":20078661},{"date":"2023-05-19","current":-5.533634,"twenty":-6.616461,"median":-6.31496,"eighty":-5.658793,"marketCap":17801699},{"date":"2023-05-26","current":-5.561302,"twenty":-6.458357,"median":-6.186271,"eighty":-5.598088,"marketCap":17890708},{"date":"2023-06-02","current":-5.262646,"twenty":-6.452842,"median":-5.82778,"eighty":-5.482158,"marketCap":16929933},{"date":"2023-06-09","current":-5.525778,"twenty":-6.449165,"median":-5.749648,"eighty":-5.42597,"marketCap":17776429},{"date":"2023-06-16","current":-5.552999,"twenty":-6.425266,"median":-5.726667,"eighty":-5.42597,"marketCap":17863998},{"date":"2023-06-23","current":-5.27172,"twenty":-6.388497,"median":-5.639618,"eighty":-5.389675,"marketCap":16959122},{"date":"2023-06-30","current":-3.937911,"twenty":-6.292899,"median":-5.570402,"eighty":-5.286238,"marketCap":12668260},{"date":"2023-07-07","current":-3.937911,"twenty":-6.252454,"median":-5.552999,"eighty":-5.259017,"marketCap":12668260},{"date":"2023-07-14","current":-2.385349,"twenty":-6.208332,"median":-5.497533,"eighty":-4.422437,"marketCap":12084177},{"date":"2023-07-21","current":-2.080028,"twenty":-6.169725,"median":-5.444117,"eighty":-3.992352,"marketCap":10537423},{"date":"2023-07-28","current":-2.074266,"twenty":-6.062039,"median":-5.398749,"eighty":-2.492577,"marketCap":10508234},{"date":"2023-08-04","current":-2.016648,"twenty":-5.895709,"median":-5.29894,"eighty":-2.286879,"marketCap":10216339},{"date":"2023-08-11","current":-1.670937,"twenty":-5.80594,"median":-5.269392,"eighty":-2.115752,"marketCap":8464966},{"date":"2023-08-18","current":-0.705381,"twenty":-5.784454,"median":-5.253573,"eighty":-2.071731,"marketCap":8123173},{"date":"2023-08-25","current":-0.379941,"twenty":-5.775512,"median":-4.672867,"eighty":-2.016648,"marketCap":4375403},{"date":"2023-09-01","current":-0.326031,"twenty":-5.745051,"median":-4.137529,"eighty":-1.921001,"marketCap":3754569},{"date":"2023-09-08","current":-0.3029,"twenty":-5.7189,"median":-4.028646,"eighty":-1.605021,"marketCap":3488202},{"date":"2023-09-15","current":-0.344001,"twenty":-5.680197,"median":-3.282658,"eighty":-0.71008,"marketCap":3961514},{"date":"2023-09-22","current":-0.388926,"twenty":-5.612229,"median":-2.48912,"eighty":-0.572479,"marketCap":4478876},{"date":"2023-09-29","current":-0.427434,"twenty":-5.570848,"median":-2.355128,"eighty":-0.40895,"marketCap":4922329},{"date":"2023-10-06","current":-0.431285,"twenty":-5.566762,"median":-2.183742,"eighty":-0.40818,"marketCap":4966674},{"date":"2023-10-13","current":-0.385076,"twenty":-5.557981,"median":-2.111719,"eighty":-0.394317,"marketCap":4434531},{"date":"2023-10-20","current":-0.30806,"twenty":-5.545253,"median":-2.080028,"eighty":-0.388156,"marketCap":3547624},{"date":"2023-10-27","current":-0.29009,"twenty":-5.537507,"median":-2.074266,"eighty":-0.385076,"marketCap":3340680},{"date":"2023-11-03","current":-0.313195,"twenty":-5.527349,"median":-2.035374,"eighty":-0.378144,"marketCap":3606751},{"date":"2023-11-10","current":-0.326031,"twenty":-5.480587,"median":-2.016648,"eighty":-0.338353,"marketCap":3754569},{"date":"2023-11-17","current":-0.236451,"twenty":-5.463669,"median":-1.982077,"eighty":-0.328085,"marketCap":3145265},{"date":"2023-11-24","current":-0.183038,"twenty":-5.451376,"median":-1.754484,"eighty":-0.323726,"marketCap":2434765},{"date":"2023-12-01","current":-0.149115,"twenty":-5.430507,"median":-1.596033,"eighty":-0.313195,"marketCap":1983522},{"date":"2023-12-08","current":-0.135594,"twenty":-5.413267,"median":-1.130208,"eighty":-0.310628,"marketCap":1803674},{"date":"2023-12-15","current":-0.104697,"twenty":-5.396934,"median":-0.705381,"eighty":-0.306725,"marketCap":1392685},{"date":"2023-12-22","current":-0.090567,"twenty":-5.373343,"median":-0.587882,"eighty":-0.302916,"marketCap":1204721},{"date":"2023-12-29","current":-0.094904,"twenty":-5.349752,"median":-0.438986,"eighty":-0.2983,"marketCap":1262416},{"date":"2024-01-05","current":-0.110474,"twenty":-5.311643,"median":-0.435136,"eighty":-0.294711,"marketCap":1469527},{"date":"2024-01-12","current":-0.109217,"twenty":-5.291682,"median":-0.427434,"eighty":-0.246147,"marketCap":1452802},{"date":"2024-01-19","current":-0.097153,"twenty":-5.278979,"median":-0.423583,"eighty":-0.216462,"marketCap":1292334},{"date":"2024-01-26","current":-0.094979,"twenty":-5.268926,"median":-0.399195,"eighty":-0.171402,"marketCap":1263405},{"date":"2024-02-02","current":-0.094661,"twenty":-5.264413,"median":-0.392777,"eighty":-0.137831,"marketCap":1259185},{"date":"2024-02-09","current":-0.06068,"twenty":-5.257202,"median":-0.388926,"eighty":-0.126623,"marketCap":807170},{"date":"2024-02-16","current":-0.051457,"twenty":-5.14469,"median":-0.385076,"eighty":-0.111663,"marketCap":684480},{"date":"2024-02-23","current":-0.04102,"twenty":-4.999514,"median":-0.382508,"eighty":-0.110454,"marketCap":545646},{"date":"2024-03-01","current":-0.03886,"twenty":-4.71642,"median":-0.375448,"eighty":-0.10718,"marketCap":516911},{"date":"2024-03-08","current":-0.039161,"twenty":-4.422437,"median":-0.344001,"eighty":-0.100549,"marketCap":520915},{"date":"2024-03-15","current":-0.03767,"twenty":-4.279076,"median":-0.334836,"eighty":-0.098655,"marketCap":501091},{"date":"2024-03-22","current":-0.038156,"twenty":-4.093976,"median":-0.328598,"eighty":-0.095596,"marketCap":507548},{"date":"2024-03-28","current":-0.03767,"twenty":-4.028646,"median":-0.326031,"eighty":-0.094235,"marketCap":501091},{"date":"2024-04-05","current":-0.0264,"twenty":-4.010499,"median":-0.323464,"eighty":-0.087028,"marketCap":344177},{"date":"2024-04-12","current":-0.125045,"twenty":-3.937911,"median":-0.313195,"eighty":-0.088985,"marketCap":1630208},{"date":"2024-04-19","current":-0.126859,"twenty":-3.67581,"median":-0.313195,"eighty":-0.09094,"marketCap":1653862},{"date":"2024-04-26","current":-0.105479,"twenty":-2.6009,"median":-0.310628,"eighty":-0.09277,"marketCap":1375129},{"date":"2024-05-03","current":-0.105185,"twenty":-2.49373,"median":-0.30806,"eighty":-0.094235,"marketCap":1371293},{"date":"2024-05-10","current":-0.10033,"twenty":-2.46953,"median":-0.302926,"eighty":-0.09471,"marketCap":1308002},{"date":"2024-05-17","current":-0.103221,"twenty":-2.390004,"median":-0.302913,"eighty":-0.094919,"marketCap":1318551},{"date":"2024-05-24","current":-0.122034,"twenty":-2.373261,"median":-0.297792,"eighty":-0.095113,"marketCap":1558863},{"date":"2024-05-31","current":-0.089235,"twenty":-2.324907,"median":-0.295225,"eighty":-0.094904,"marketCap":1139886},{"date":"2024-06-07","current":-0.082262,"twenty":-2.229836,"median":-0.270731,"eighty":-0.09243,"marketCap":1050809},{"date":"2024-06-14","current":-0.067369,"twenty":-2.183742,"median":-0.243952,"eighty":-0.086638,"marketCap":860576},{"date":"2024-06-21","current":-0.06046,"twenty":-2.183742,"median":-0.236451,"eighty":-0.084684,"marketCap":772312},{"date":"2024-06-28","current":-0.04364,"twenty":-2.142256,"median":-0.183038,"eighty":-0.080138,"marketCap":557458},{"date":"2024-07-05","current":-0.035685,"twenty":-2.107685,"median":-0.169273,"eighty":-0.077002,"marketCap":455838},{"date":"2024-07-12","current":-0.039549,"twenty":-2.084638,"median":-0.148382,"eighty":-0.067451,"marketCap":505197},{"date":"2024-07-19","current":-0.133962,"twenty":-2.080028,"median":-0.136425,"eighty":-0.065043,"marketCap":1711236},{"date":"2024-07-26","current":-0.250214,"twenty":-2.076571,"median":-0.134227,"eighty":-0.066114,"marketCap":3196229},{"date":"2024-08-02","current":-0.123557,"twenty":-2.070463,"median":-0.136308,"eighty":-0.067151,"marketCap":1578317},{"date":"2024-08-09","current":-0.119179,"twenty":-2.057903,"median":-0.134149,"eighty":-0.067451,"marketCap":1522398},{"date":"2024-08-16","current":-0.173723,"twenty":-2.032205,"median":-0.134188,"eighty":-0.068945,"marketCap":1438081},{"date":"2024-08-23","current":-0.180019,"twenty":-2.0178,"median":-0.137022,"eighty":-0.072461,"marketCap":1490194},{"date":"2024-08-30","current":-0.179523,"twenty":-2.016648,"median":-0.143852,"eighty":-0.075548,"marketCap":1486095},{"date":"2024-09-06","current":-0.181256,"twenty":-2.012038,"median":-0.150555,"eighty":-0.076825,"marketCap":1500441},{"date":"2024-09-13","current":-0.17772,"twenty":-1.99821,"median":-0.158633,"eighty":-0.077735,"marketCap":1471164},{"date":"2024-09-20","current":-0.155898,"twenty":-1.983229,"median":-0.162446,"eighty":-0.078438,"marketCap":1290525},{"date":"2024-09-27","current":-0.157737,"twenty":-1.921001,"median":-0.162689,"eighty":-0.07939,"marketCap":1305749},{"date":"2024-10-04","current":-0.126614,"twenty":-1.771193,"median":-0.158185,"eighty":-0.081212,"marketCap":1048113},{"date":"2024-10-11","current":-0.142706,"twenty":-1.649964,"median":-0.155898,"eighty":-0.082328,"marketCap":1181323},{"date":"2024-10-18","current":-0.205129,"twenty":-1.609516,"median":-0.156191,"eighty":-0.082669,"marketCap":1698060},{"date":"2024-10-25","current":-0.253618,"twenty":-1.58474,"median":-0.158633,"eighty":-0.083857,"marketCap":2099446},{"date":"2024-11-01","current":-0.389038,"twenty":-1.55835,"median":-0.162689,"eighty":-0.085216,"marketCap":3220459},{"date":"2024-11-08","current":-0.309533,"twenty":-1.213002,"median":-0.16573,"eighty":-0.0855,"marketCap":2562314},{"date":"2024-11-15","current":-0.834738,"twenty":-0.956624,"median":-0.168878,"eighty":-0.086051,"marketCap":6897440},{"date":"2024-11-22","current":-0.744896,"twenty":-0.798801,"median":-0.172945,"eighty":-0.087419,"marketCap":6155078},{"date":"2024-11-29","current":-0.73895,"twenty":-0.817115,"median":-0.173652,"eighty":-0.088719,"marketCap":6105945},{"date":"2024-12-06","current":-0.85409,"twenty":-0.817115,"median":-0.175474,"eighty":-0.089501,"marketCap":7057347},{"date":"2024-12-13","current":-0.864901,"twenty":-0.90556,"median":-0.177225,"eighty":-0.09094,"marketCap":7146680},{"date":"2024-12-20","current":-0.800034,"twenty":-0.862739,"median":-0.178604,"eighty":-0.092559,"marketCap":6610679},{"date":"2024-12-27","current":-0.840252,"twenty":-0.85409,"median":-0.179258,"eighty":-0.093076,"marketCap":6943000},{"date":"2025-01-03","current":-0.980582,"twenty":-0.899629,"median":-0.179576,"eighty":-0.093918,"marketCap":8102549},{"date":"2025-01-10","current":-0.824359,"twenty":-0.897162,"median":-0.179967,"eighty":-0.094448,"marketCap":6811680},{"date":"2025-01-17","current":-0.778736,"twenty":-0.894437,"median":-0.183038,"eighty":-0.094807,"marketCap":6434692},{"date":"2025-01-24","current":-0.664677,"twenty":-0.882156,"median":-0.183767,"eighty":-0.094934,"marketCap":5492224},{"date":"2025-01-31","current":-0.683272,"twenty":-0.864036,"median":-0.186432,"eighty":-0.095246,"marketCap":5645877},{"date":"2025-02-07","current":-0.51786,"twenty":-0.859279,"median":-0.188825,"eighty":-0.095801,"marketCap":4279075},{"date":"2025-02-14","current":-0.59462,"twenty":-0.851712,"median":-0.211495,"eighty":-0.096227,"marketCap":4913342},{"date":"2025-02-21","current":-0.448668,"twenty":-0.847171,"median":-0.237801,"eighty":-0.096648,"marketCap":3707340},{"date":"2025-02-28","current":-0.503678,"twenty":-0.842674,"median":-0.243952,"eighty":-0.097277,"marketCap":4161888},{"date":"2025-03-07","current":-0.417118,"twenty":-0.839149,"median":-0.250793,"eighty":-0.097785,"marketCap":3446642},{"date":"2025-03-14","current":-0.38344,"twenty":-0.834284,"median":-0.285059,"eighty":-0.097973,"marketCap":3146894},{"date":"2025-03-21","current":-0.529391,"twenty":-0.832468,"median":-0.291725,"eighty":-0.098547,"marketCap":4344710},{"date":"2025-03-28","current":-0.279508,"twenty":-0.831517,"median":-0.292657,"eighty":-0.098601,"marketCap":2293923},{"date":"2025-04-04","current":-0.09666,"twenty":-0.827041,"median":-0.290527,"eighty":-0.098547,"marketCap":793290},{"date":"2025-04-11","current":-0.085138,"twenty":-0.823818,"median":-0.279508,"eighty":-0.096759,"marketCap":698726},{"date":"2025-04-17","current":-0.09666,"twenty":-0.821656,"median":-0.251372,"eighty":-0.09666,"marketCap":793290},{"date":"2025-04-25","current":-0.116504,"twenty":-0.814953,"median":-0.245324,"eighty":-0.09666,"marketCap":956151},{"date":"2025-05-02","current":-0.134428,"twenty":-0.809764,"median":-0.239152,"eighty":-0.09666,"marketCap":1103251},{"date":"2025-05-09","current":-0.0941,"twenty":-0.808683,"median":-0.211495,"eighty":-0.09666,"marketCap":772276},{"date":"2025-05-16","current":-0.084138,"twenty":-0.800034,"median":-0.204843,"eighty":-0.096031,"marketCap":788037},{"date":"2025-05-23","current":-0.070115,"twenty":-0.798953,"median":-0.187157,"eighty":-0.094904,"marketCap":656697},{"date":"2025-05-30","current":-0.343344,"twenty":-0.795147,"median":-0.196834,"eighty":-0.094964,"marketCap":3215762},{"date":"2025-06-06","current":-0.358381,"twenty":-0.793245,"median":-0.205801,"eighty":-0.0953,"marketCap":3356598}],"updateTime":1749331189248}}}